Stock Crash: MNC drugmaker shares tank after key drug fails to get regulatory panel nod

July 18, 2025
Uncategorized

In a statement post the developments, GSK said that it remains confident in Blenrep’s safety and efficacy and will work with the USFDA, as it reviews the drug.

Stock Crash: MNC drugmaker shares tank after key drug fails to get regulatory panel nod

Leave a ReplyCancel Reply

Explained | RBI to tighten lending norms for brokers from April 1 — key changes and impact

Ola Electric shares downgraded, target price cut by 60% after revenue halves in Q3; Stock down 6%

Alibaba leads tech slide after Pentagon briefly shows blacklist

Blue Jet Healthcare shares tumble 10% after JPMorgan downgrade, 17% downside seen

GMR Airports shares gain 5% after Jefferies flags 25% upside on strong Q3 performance